Algorithmiq simulated excited-state dynamics of a Phase II clinical trial photosensitizer — not hydrogen, a real cancer drug — on up to 100 qubits, and won the $2M Wellcome Leap Q4Bio prize for it.
newquantumera.comQuantum Drug Discovery and the Path to Advantage with Sabrina ManiscalcoWhat does it actually take to run a quantum-classical workflow on a real cancer drug — not hydrogen, not a toy molecule, but a photosensitizer already in Phase II clinical trials? Sabrina Maniscalco, CEO and co-founder of Algorithmiq, joins Sebastian to unpack the science behind the company's…
0 reposts2 likes